Table 2 Risk factors associated with concurrent cancer as calculated using logistic regression modeling among 1946 HIV-infected inpatients at Beijing Ditan Hospital, January 1, 2008 – December 31, 2013
From: Prevalence and mortality of cancer among HIV-infected inpatients in Beijing, China
Characteristic | OR (95 % CI) | p-value | Adjusted OR (95 % CI) | p-value |
|---|---|---|---|---|
Total | ||||
Gender | ||||
Female | 1.00 | 1.00 | ||
Male | 0.68 (0.47–0.99) | 0.042 | 0.68 (0.45–1.05) | 0.422 |
Age group every 10-year increase | 1.05 (1.03–1.06) | 0.011 | 1.05 (1.03–1.06) | 0.001 |
HIV transmission mode | ||||
Men who have sex with men | 1.00 | 1.00 | ||
Injection drug use | 0.45 (0.11–1.90) | 0.156 | 0.37 (0.09–1.61) | 0.085 |
Heterosexual contact | 1.88 (1.25–2.83) | 0.037 | 1.42 (0.84–1.82) | 0.524 |
Blood transmission | 1.94 (1.13–3.34) | 0.041 | 1.07 (0.86–1.32) | 0.554 |
Unknown | 1.59 (0.60–4.22) | 0.263 | 0.89 (0.32–2.54) | 0.734 |
First CD4 cell count after HIV diagnosis (cells/μl) | ||||
0–200 | 1.00 | 1.00 | ||
201–350 | 0.87 (0.56–1.35) | 0.533 | 1.08 (0.67–1.75) | 0.745 |
351–500 | 0.86 (0.55–1.35) | 0.514 | 1.02 (0.63–1.64) | 0.950 |
> 500 | 0.57 (0.32–1.02) | 0.057 | 0.71 (0.39–1.30) | 0.263 |
ART initiation before the first hospital admission | ||||
Yes | 1.00 | 1.00 | ||
No | 1.86 (1.33–2.60) | 0.01 | 2.07 (1.42–3.01) | 0.001 |